Aura Biosciences, Inc.AURANASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+6.9%
5Y CAGR+39.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+6.9%/yr
Annual compound
5Y CAGR
+39.5%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
5.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$22.03M-3.4%
2024$22.81M+15.5%
2023$19.76M+9.4%
2022$18.06M+79.0%
2021$10.09M+142.3%
2020$4.16M-7.9%
2019$4.52M-